HOME > 研究業績詳細
研究業績詳細
土師 正太郎(ハジ ショウタロウ)
| 研究テーマ | パーキンソン病・筋萎縮性側索硬化症における画像バイオマーカーの開発、メタ解析を用いたエビデンス確立 |
|---|---|
| 研究業績(論文) | 1: Haji S, Sako W, Hanada K, Matsubara T, Osaki Y, Matsumoto Y, Harada M, Izumi Y. Magnetic Susceptibility and Area in the Subthalamic Nucleus Measured by QSM for Diagnosis of Progressive Supranuclear Palsy. Mov Disord Clin Pract. 2025 May 29. doi: 10.1002/mdc3.70153. Epub ahead of print. PMID: 40439086. 2: Osaki Y, Nodera H, Sato R, Haji S, Fujita K, Miyamoto R, Muto K, Yamazaki H, Morino H, Kanda T, Murayama S, Kaji R, Izumi Y. Peripheral nerve excitability abnormalities in Neuronal Intranuclear Inclusion Disease: Assessment with histopathological analysis. Clin Neurophysiol. 2025 Feb;170:156-167. doi: 10.1016/j.clinph.2024.12.013. Epub 2024 Dec 14. PMID: 39724790. 3: Nakamura K, Fujita K, Suzuki M, Kunugi A, Hirozane Y, Kunikata T, Takahashi B, Narazaki G, Kondo H, Haji S, Hirai K, Izumi Y. Neuroinflammation and glycosylation-related cerebrospinal fluid proteins for predicting functional decline in amyotrophic lateral sclerosis: a proteomic study. Front Neurol. 2024 Nov 18;15:1418320. doi: 10.3389/fneur.2024.1418320. PMID: 39624674; PMCID: PMC11608993. 4: Imamura K, Izumi Y, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Murakami T, Hanajima R, Kataoka H, Kiriyama T, Nanaura H, Sugie K, Hirayama T, Kano O, Nakamori M, Maruyama H, Haji S, Fujita K, Atsuta N, Tatebe H, Tokuda T, Takahashi N, Morinaga A, Tabuchi R, Oe M, Kobayashi M, Lobello K, Morita S, Sobue G, Takahashi R, Inoue H. Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study. BMJ Open. 2024 Oct 26;14(10):e082142. doi: 10.1136/bmjopen-2023-082142. PMID: 39461864; PMCID: PMC11529471. 5: Hanada K, Osaki Y, Miyamoto R, Muto K, Haji S, Nazere K, Kuwano Y, Morino H, Azuma Y, Miyatake S, Matsumoto N, Izumi Y. Intermediate phenotype between CMT2Z and DIGFAN associated with a novel MORC2 variant: a case report. Hum Genome Var. 2024 Aug 15;11(1):29. doi: 10.1038/s41439-024-00287-8. PMID: 39143067; PMCID: PMC11324651. 6: Haji S, Sako W, Murakami N, Osaki Y, Izumi Y. Factors associated with a placebo effect in Parkinson's disease in clinical trials: a meta-analysis. J Neurol. 2024 Sep;271(9):5825-5837. doi: 10.1007/s00415-024-12529-4. Epub 2024 Jul 2. PMID: 38955829. 7: Yamamoto Y, Fujita K, Yamazaki H, Haji S, Osaki Y, Izumi Y. Constipation in patients with motor neuron disease: A retrospective longitudinal study. Heliyon. 2024 Mar 13;10(6):e27951. doi: 10.1016/j.heliyon.2024.e27951. PMID: 38524582; PMCID: PMC10957436. 8: Haji S, Miyamoto R, Morino H, Osaki Y, Tsuji S, Nishino I, Abe M, Izumi Y. Autosomal Recessive Spinocerebellar Ataxia Type 9 With a Response to Phosphate Repletion: A Case Report. Neurol Genet. 2023 May 9;9(3):e200070. doi: 10.1212/NXG.0000000000200070. PMID: 37529414; PMCID: PMC10389171. 9: Haji S, Fujita K, Oki R, Osaki Y, Miyamoto R, Morino H, Nagano S, Atsuta N, Kanazawa Y, Matsumoto Y, Arisawa A, Kawai H, Sato Y, Sakaguchi S, Yagi K, Hamatani T, Kagimura T, Yanagawa H, Mochizuki H, Doyu M, Sobue G, Harada M, Izumi Y. An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC- ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study. JMIR Res Protoc. 2023 Jan 30;12:e42032. doi: 10.2196/42032. PMID: 36716091; PMCID: PMC9926342. 10: Sako W, Haji S, Abe T, Osaki Y, Matsumoto Y, Harada M, Izumi Y. M1/precuneus ratio as a surrogate marker of upper motor neuron sign in ALS. J Neurol Sci. 2023 Feb 15;445:120548. doi: 10.1016/j.jns.2023.120548. Epub 2023 Jan 7. PMID: 36640663. 11: Fukushima K, Takamatsu N, Yamamoto Y, Yamazaki H, Yoshida T, Osaki Y, Haji S, Fujita K, Sugie K, Izumi Y. Early diagnosis of amyotrophic lateral sclerosis based on fasciculations in muscle ultrasonography: A machine learning approach. Clin Neurophysiol. 2022 Aug;140:136-144. doi: 10.1016/j.clinph.2022.06.005. Epub 2022 Jun 17. PMID: 35772191. 12: Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. PMID: 35532908; PMCID: PMC9086935. 13: Haji S, Sako W, Murakami N, Osaki Y, Izumi Y. Serum NfL and CHI3L1 for ALS and parkinsonian disorders in the process of diagnosis. J Neural Transm (Vienna). 2022 Mar;129(3):301-309. doi: 10.1007/s00702-022-02470-z. Epub 2022 Feb 18. PMID: 35178615. 14: Sako W, Abe T, Matsumoto Y, Nakamura K, Haji S, Osaki Y, Harada M, Izumi Y. The Cerebellum Is a Common Key for Visuospatial Execution and Attention in Parkinson's Disease. Diagnostics (Basel). 2021 Jun 6;11(6):1042. doi: 10.3390/diagnostics11061042. PMID: 34204073; PMCID: PMC8229154. 15: Haji S, Sako W, Murakami N, Osaki Y, Furukawa T, Izumi Y, Kaji R. The value of serum uric acid as a prognostic biomarker in amyotrophic lateral sclerosis: Evidence from a meta-analysis. Clin Neurol Neurosurg. 2021 Apr;203:106566. doi: 10.1016/j.clineuro.2021.106566. Epub 2021 Feb 19. PMID: 33706058. 16: Sako W, Izumi Y, Abe T, Haji S, Murakami N, Osaki Y, Matsumoto Y, Harada M, Kaji R. MR spectroscopy and imaging-derived measurements in the supplementary motor area for biomarkers of amyotrophic lateral sclerosis. Neurol Sci. 2021 Oct;42(10):4257-4263. doi: 10.1007/s10072-021-05107-3. Epub 2021 Feb 17. PMID: 33594539. 17: Naito N, Kawano H, Yamashita Y, Kondo M, Haji S, Miyamoto R, Toyoda Y, Kanematsu Y, Izumi Y, Bando Y, Nishioka Y. Neuropsychiatric systemic lupus erythematosus with cerebellar vasculitis and obstructive hydrocephalus requiring decompressive craniectomy. Mod Rheumatol Case Rep. 2021 Jan;5(1):52-57. doi: 10.1080/24725625.2020.1826626. Epub 2020 Oct 9. PMID: 33021438. 18: Murakami N, Sako W, Haji S, Furukawa T, Otomi Y, Otsuka H, Izumi Y, Harada M, Kaji R. Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy. J Neurol Sci. 2020 Feb 15;409:116627. doi: 10.1016/j.jns.2019.116627. Epub 2019 Dec 16. PMID: 31865188. 19: Sako W, Abe T, Haji S, Murakami N, Osaki Y, Izumi Y, Harada M, Kaji R. "One line": A method for differential diagnosis of parkinsonian syndromes. Acta Neurol Scand. 2019 Sep;140(3):229-235. doi: 10.1111/ane.13136. Epub 2019 Jun 21. PMID: 31225648. 20: Murakami N, Sako W, Haji S, Furukawa T, Otomi Y, Otsuka H, Izumi Y, Harada M, Kaji R. Potential Utility of <sup>123</sup>I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease. Front Neurol. 2019 Apr 12;10:376. doi: 10.3389/fneur.2019.00376. PMID: 31031701; PMCID: PMC6473994. 21: Sako W, Abe T, Furukawa T, Oki R, Haji S, Murakami N, Izumi Y, Harada M, Kaji R. Differences in the intra-cerebellar connections and graph theoretical measures between Parkinson's disease and multiple system atrophy. J Neurol Sci. 2019 May 15;400:129-134. doi: 10.1016/j.jns.2019.03.022. Epub 2019 Mar 25. PMID: 30928779. 22: Haji S, Eto F, Torii T. Multijoint Pain and Pulmonary Calcification with Long-term Hemodialysis. Intern Med. 2018 Oct 15;57(20):3063-3064. doi: 10.2169/internalmedicine.0443-17. Epub 2018 May 18. PMID: 29780115; PMCID: PMC6232024. 23: Muto K, Matsui N, Unai Y, Sakai W, Haji S, Udaka K, Miki H, Furukawa T, Abe M, Kaji R. Memory B cell resurgence requires repeated rituximab in myasthenia gravis. Neuromuscul Disord. 2017 Oct;27(10):918-922. doi: 10.1016/j.nmd.2017.06.012. Epub 2017 Jun 21. PMID: 28694074. 24: Yoshida T, Mizuta I, Saito K, Kimura Y, Park K, Ito Y, Haji S, Nakagawa M, Mizuno T. Characteristic abnormal signals in medulla oblongata-"eye spot" sign: Four cases of elderly-onset Alexander disease. Neurol Clin Pract. 2015 Jun;5(3):259-262. doi: 10.1212/CPJ.0000000000000124. PMID: 29443213; PMCID: PMC5764465. 25: Haji S, Kimura H, Yamashita H. Arthritis and bacteremia due to Leclercia adecarboxylata. Intern Med. 2014;53(22):2659. doi: 10.2169/internalmedicine.53.2990. Epub 2014 Nov 15. PMID: 25400198. |
| 研究者 | 教育活動 | researchmap(JST) | ホームページURL |
